
GC73227
hCAIX-IN-18
Also known as 4-[4-[(E)-C-(4-chlorophenyl)-N-hydroxycarbonimidoyl]piperazin-1-yl]benzenesulfonamide
hCAIX-IN-18 (compound 30) is an inhibitor of carbonic andrase (CA), with Kis of 3·5 nM, 9·4 nM, 43·0 nM and 8·2 nM for hCAI, hCAII, hCAIX, hCAXII, respectively
ChemicalCAS2925261-76-1MW394.88FormulaC17H19ClN4O3S
- CAS number
- 2925261-76-1
- Molecular weight
- 394.88
- Formula
- C17H19ClN4O3S
- Solubility
- DMSO : 50 mg/mL (126·62 mM; ultrasonic and warming and heat to 80°C)
- InChIKey
- WOCYSDBHUJLEPT-LVZFUZTISA-N
- Catalogue number
- GC73227
- Brand
- GLPBIO
Computed properties PubChem CID 171356273 · XLogP 2.4 · TPSA 108 Ų · H-bond donors 2
- XLogP
- 2.4
- TPSA
- 108 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 26
SMILES C1CN(CCN1C2=CC=C(C=C2)S(=O)(=O)N)/C(=N/O)/C3=CC=C(C=C3)Cl
Computed descriptors from PubChem (CID 171356273), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il